Featured Articles

The Influence of Dermatologists’ Use of Social Media on Attracting Patients

By April 29, 2020No Comments

JDD Multimedia

Featured Article

Emily C. Murphy BS, Kamaria Nelson MD, and Adam J. Friedman MD

In a new article, published in the May 2020 issue of the JDD,  “The Influence of Dermatologists’ Use of Social Media on Attracting Patients,” authors Emily C. Murphy BS,a,b Kamaria Nelson MD,a and Adam J. Friedman MDa examine how social media influences patients when choosing a dermatologist and the aspects of dermatologists’ sites that offer the most benefits to patients.

Read Article Now

"The Influence of Dermatologists’ Use of Social Media on Attracting Patients"

As of 2019, 79% of Americans have a social media profile, with the majority using platforms such as Facebook, Twitter, YouTube, and Instagram.1 Social media was originally created to connect with family and friends, but individuals now use it to self-promote, to disseminate information, and for activism.

Physicians are even more likely to use social media than the general population, with 87% having an account in 2011.2 In the medical community, social media allows for the distribution of health information and may increase healthcare access by connecting patients and physicians.3,4 Despite these benefits, there is also concern among practitioners about the misuse of social media given its lack of regulation, which may lead to inappropriate online consultations, spread of false information, and HIPAA violations.3

In a new article, published in the May 2020 issue of the JDD,  “The Influence of Dermatologists’ Use of Social Media on Attracting Patients,” authors Emily C. Murphy BS,a,b Kamaria Nelson MD,a and Adam J. Friedman MDa examine how social media influences patients when choosing a dermatologist and the aspects of dermatologists’ sites that offer the most benefits to patients.

Read Article Now

You May Also Like

AcneFeatured ArticlesLatest NewsThe Latest
September 25, 2025

From the Vault: Integrated Short-Term and Long-Term Efficacy of Topical Clascoterone Cream 1% in Patients Aged 12 Years or Older With Acne Vulgaris

Clascoterone Keeps Gaining Ground in Acne Two identical Phase 3 trials (plus a long‑term extension) randomized patients ≥12 years with moderate‑to‑severe acne to twice‑daily clascoterone 1% cream or vehicle for…
Journal of Drugs in Dermatology JDD Article About Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic AlopeciaAlopeciaFeatured ArticlesLatest NewsThe Latest
September 24, 2025

Microneedling Combined With Drugs and Stem Cells for Treating Androgenetic Alopecia

Small Channels, Smarter Delivery -  A Practical Boost For Topical And Regenerative Approaches Microneedling is proving to be a low‑risk, clinic-friendly way to enhance topical therapies (most consistently 5% minoxidil, now…
Journal of Drugs in Dermatology JDD Article About The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart ReviewAtopic DermatitisFeatured ArticlesLatest NewsThe Latest
September 24, 2025

The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart Review

Dupilumab in Diverse Skin — Are Adverse Events Really the Same? Atopic dermatitis isn’t one-size-fits-all: chronic type 2 inflammation, barrier dysfunction, and S. aureus colonization are core features, but presentation…

Leave a Reply